HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ito, H. Articles by Farde, L. Search for Related Content PubMed PubMed Citation Articles by Ito, H. Articles by Farde, L.

PET Imaging of Central 5-HT_2A Receptors with Carbon-11-MDL 100,907

Karolinska Institutet and Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, Stockholm, Sweden

Correspondence: For correspondence or reprints contact: Hiroshi Ito, MD, Department of Clinical Neuroscience, Psychiatry Section, Karolinska Hospital, S-171 76 Stockholm, Sweden.

ABSTRACT

Serotonergic 5-HT_2A receptors are of central interest in the complex pathophysiology of schizophrenia. These receptors have also been proposed as putative targets for atypical antipsychotic drugs. Suitable radioligands for 5-HT_2A receptors are required to evaluate this hypothesis in vivo with PET. MDL 100,907 is a highly selective 5-HT_2A receptor antagonist that is currently being developed as a potential antipsychotic drug. We have previously reported on the preparation of [¹¹C]MDL 100,907 and initial characterization of [¹¹C]MDL 100,907 binding in the monkey brain. In this preliminary PET study, the regional distribution and binding kinetics of [¹¹C]MDL 100,907 were examined in healthy men. Methods: A PET examination was performed in each of three subjects after intravenous injection of [¹¹C]MDL 100,907. The metabolite-corrected arterial input function was used in a kinetic analysis according to the standard three-compartment model. Results: The highest radioactivity concentration was observed in the neocortex, whereas radioactivity was lower in the cerebellum, pons, thalamus, striatum and white matter. The binding potential (BP) in the neocortical regions was 4–6 times higher, whereas BP in the striatum was slightly higher than that in the cerebellum, demonstrating a regional distribution in good agreement with 5-HT_2A receptor densities measured in vitro. The BP in the cerebellum was small but not negligible. Conclusion: This preliminary study suggests that [¹¹C]MDL 100,907 is a suitable PET radioligand for studies on 5-HT_2A receptors in man. The high selectivity of MDL 100,907 represents a major advantage as compared to presently available radioligands with poor selectivity. Thus, [¹¹C]MDL 100,907 is recommended in the future for PET studies in healthy subjects and schizophrenic patients, including the determination of drug-induced 5-HT_2A receptor occupancy.

Key Words: serotonergic receptor • brain • PET • schizophrenia

This article has been cited by other articles:

				Z. Bhagwagar, R. Hinz, M. Taylor, S. Fancy, P. Cowen, and P. Grasby Increased 5-HT2A Receptor Binding in Euthymic, Medication-Free Patients Recovered From Depression: A Positron Emission Study With [11C]MDL 100,907 Am J Psychiatry, September 1, 2006; 163(9): 1580 - 1587. [Abstract] [Full Text] [PDF]

				R. M. Moresco, R. Cavallaro, C. Messa, D. Bravi, C. Gobbo, L. Galli, G. Lucignani, C. Colombo, G. Rizzo, I. Velona, et al. Cerebral D2 and 5-HT2 Receptor occupancy in Schizophrenic Patients Treated with Olanzapine Or Clozapine J Psychopharmacol, September 1, 2004; 18(3): 355 - 365. [Abstract] [PDF]